Li Y - Search Results

1

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.

Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA. Wargo JA, et al. Among authors: li y. Cancer Immunol Immunother. 2009 Mar;58(3):383-94. doi: 10.1007/s00262-008-0562-x. Epub 2008 Aug 2. Cancer Immunol Immunother. 2009. PMID: 18677478 Free PMC article.

2

Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.

Robbins PF, el-Gamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Appella E, Kawakami Y, Rosenberg SA. Robbins PF, et al. Among authors: li yf. J Immunol. 1995 Jun 1;154(11):5944-50. J Immunol. 1995. PMID: 7751637

3

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA. Robbins PF, et al. Among authors: li yf. J Exp Med. 1996 Mar 1;183(3):1185-92. doi: 10.1084/jem.183.3.1185. J Exp Med. 1996. PMID: 8642260 Free PMC article.

4

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.

Topalian SL, Gonzales MI, Parkhurst M, Li YF, Southwood S, Sette A, Rosenberg SA, Robbins PF. Topalian SL, et al. Among authors: li yf. J Exp Med. 1996 May 1;183(5):1965-71. doi: 10.1084/jem.183.5.1965. J Exp Med. 1996. PMID: 8642306 Free PMC article.

5

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.

Bloom MB, Perry-Lalley D, Robbins PF, Li Y, el-Gamil M, Rosenberg SA, Yang JC. Bloom MB, et al. Among authors: li y. J Exp Med. 1997 Feb 3;185(3):453-9. doi: 10.1084/jem.185.3.453. J Exp Med. 1997. PMID: 9053445 Free PMC article.

6

The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.

Robbins PF, El-Gamil M, Li YF, Fitzgerald EB, Kawakami Y, Rosenberg SA. Robbins PF, et al. Among authors: li yf. J Immunol. 1997 Jul 1;159(1):303-8. J Immunol. 1997. PMID: 9200467

7

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.

Touloukian CE, Leitner WW, Topalian SL, Li YF, Robbins PF, Rosenberg SA, Restifo NP. Touloukian CE, et al. Among authors: li yf. J Immunol. 2000 Apr 1;164(7):3535-42. doi: 10.4049/jimmunol.164.7.3535. J Immunol. 2000. PMID: 10725708 Free PMC article.

8

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

Panelli MC, Bettinotti MP, Lally K, Ohnmacht GA, Li Y, Robbins P, Riker A, Rosenberg SA, Marincola FM. Panelli MC, et al. Among authors: li y. J Immunol. 2000 Apr 15;164(8):4382-92. doi: 10.4049/jimmunol.164.8.4382. J Immunol. 2000. PMID: 10754339

9

Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells.

Harada M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Harada M, et al. Among authors: li yf. Cancer Res. 2001 Feb 1;61(3):1089-94. Cancer Res. 2001. PMID: 11221837

10

Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types.

Harada M, Li YF, El-Gamil M, Ohnmacht GA, Rosenberg SA, Robbins PF. Harada M, et al. Among authors: li yf. J Immunother. 2001 Jul-Aug;24(4):323-33. doi: 10.1097/00002371-200107000-00008. J Immunother. 2001. PMID: 11565834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235,051 results

Search Page

Filters